EMST and Swallowing in Long-Term Survivors of HNCA
Reason given: Poor accruals
Key facts
- Where
- Milwaukee, United StatesSee the 2 sites
Where in United States
- Froedtert HospitalMilwaukee, United StatesNo longer taking part
- University of Wisconsin MilwaukeeMilwaukee, United StatesNo longer taking part
Trial details
- Who runs it
- University of Wisconsin, Milwaukee
- Trial code
- NCT03975465
- Record updated
- 6 December 2024
- Original description
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on oral intake, swallowing function, and swallow-related quality of life in persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously.Read full original descriptionShow less
Effects of Expiratory Muscle Strength Training (EMST) on Long-Term Swallowing Dysfunction in Persons With Head and Neck Cancer (HNCA) Post Irradiation (RT)
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on oral intake, swallowing function, and swallow-related quality of life in persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously.
Inclusion: Subject was treated for cancer in the oral cavity, oropharynx, hypopharynx, larynx, or for an unknown primary at least 5 years prior to enrollment. Subjects may have had surgery as long as a minimum dose of 50 Gy of radiation was part of the treatment; Subject must have a current swallow complaint or impairment; these include but are not limited to reduced oral intake, perceived difficulty with bolus transport (e.g. feeling of food sticking in throat); aspiration on various bolus consistencies; Ability to follow directions and engage in a program of rehabilitation.
Exclusion: the subject's swallowing problems are unrelated to treatment for HNCA (e.g. cognitive impairment, history of stroke); the subject presents with contraindications for EMST as specified in the EMST150 package insert unless cleared for participation by the subject's physician. These conditions include untreated hypertension, untreated gastroesophageal reflux diseas, recent stroke, lung disease, and pregnancy.